I think we are in a situation in which the regulatory environment is a little confused. The CIHR has jurisdiction over all aspects of research, and I think the stem cell oversight committee of CIHR does a very good job. That is the number one thing we should focus on, making sure that we have one system for the research.
But it is more complicated than that, because there are legal aspects as well. Our overriding goal is that whatever regulatory frameworks are set up, they should be harmonized. So if we have to have—and we probably will have—multiple regulations on different aspects of stem cell research and of course their application, there needs to be harmonization across all of those. That's the one thing I think I would really make a plea for.